Call us : USA : 1-631-381-2994; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Novel Nanotechnology Platform Is Expected to Accelerate the Research in the Field of Stem Cell Transplantation

Novel Nanotechnology Platform Is Expected to Accelerate the Research in the Field of Stem Cell Transplantation

September 17, 2019Antibody Engineering Research, NewsCell Characterization, Nanotechnology, Stem Cell Transplantationbiolabs

In a study published in the international journal ACS Nano, scientists from Rutgers University have developed a new nanotechnology. It may accelerate the research in the field of stem cell transplantation andRead More…

How to Develop Immunotherapeutic Drugs?

August 6, 2019Drug Discovery Research, Immunotherapy ResearchCAR-T, immunotherapy, Therapeutic Antibodybiolabs

The high cost of cancer drugs makes it difficult for public and private health care systems to provide patients with up-to-date treatment. If this trend continues, it will be increasingly difficult forRead More…

Antibody Drugs and Cell Therapy for Tumor Microenvironment

July 16, 2019Antibody Engineering Research, Drug Discovery Research, Immunotherapy ResearchAntibody Discovery, CAR-T, immunotherapy, Tumor Microenvironmentbiolabs

According to the World Health Organization (WHO), cancer is the second leading cause of death in the world. In 2018 alone, 9.6 million people worldwide died of cancer, accounting for about 1/6Read More…

Monoclonal Drug Development and Market Conditions

June 19, 2019Biological Knowledge, Newsantibody development, Antibody Discovery, monoclonal antibody, Therapeutic Antibodybiolabs

B lymphocytes can only produce a proprietary antibody against an antigen determinant, so it has the characteristics of highly specific physical and chemical properties, single biological activity, strong binding specificity with antigenRead More…

Focus on the Technology Bottleneck of Monoclonal Antibody Drugs

May 30, 2019Antibody Engineering Research, Biological Knowledge, Drug Discovery Researchantibody development, Humanized Antibody, monoclonal antibody, Therapeutic Antibodybiolabs

The Antibodies are secreted by plasma cells transformed from B cells, and each B cell line can produce only one specific antigenic determinant. The antibody, produced from a single cell line, isRead More…

Antibodies Cure Guinea Pigs Infected with Ebola Virus, Raising Hopes for Human Treatment of Ebola

May 16, 2019Drug Discovery Research, NewsAntibody Discovery, Human Antibody, Therapeutic Antibodybiolabs

The outbreak of Ebola in 2014 in West Africa killed more than 11000 people. At the time, scientists were working on several experimental vaccines and treatments, but none of them were approvedRead More…

Based on Single Domain Antibody CAR-T Cells Are Expected to Treat Solid Tumors

April 25, 2019Antibody Engineering Research, Immunotherapy ResearchAntibody Discovery, CAR-T, Nanobodies, single domain antibodybiolabs

Most CAR-T cell therapies require targeting cancer cell-specific antigens. Now, there is a new way to target the environment around the tumor, which comes from nanobodies naturally produced by free alpacas, camelsRead More…

Nat Commun: Melanin Nanoparticles Help Alleviate the Deterioration of Cancer

April 8, 2019Drug Discovery Research, NewsMelanin, Nanoparticles, Therapeutic Diagnostics, Tumor Imagingbiolabs

Melanin protects us from the sun’s destructive rays by absorbing light energy and converting it into heat. A recent study has shown that this can make it a very effective tool forRead More…

Nat Cell Bio: “Mirror” Synthetic Biology Technology to Improve the Therapeutic Effect of Antibody Molecules

March 25, 2019Antibody Engineering Research, Drug Discovery Research, NewsAntibody Discovery, protein engineering, Therapeutic Antibodybiolabs

Scientists, from the German Cancer Research Center (DKFZ), have successfully reconstructed biomolecules in the form of images. The goal of the researchers is to create a mirror artificial protein synthesis system. InRead More…

Next the Middle of a Whirlwind: Alzheimer’s Disease Diagnostic Market

March 3, 2019Biological Knowledge, NewsAlzheimer's Disease, Diagnostic Market, Tau Protein, β-Amyloid Proteinbiolabs

Alzheimer’s disease (AD) is a neurodegenerative disease common in the elderly. The main pathological changes were diffuse atrophy of cerebral cortex, neurofibrillary tangles and the formation of a large number of senileRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Three)
  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two)
  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part One)
  • Sci Rep: Monoclonal Antibody can Effectively Treat Malaria
  • Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape

Archives

Contact Us

Address: USA – UK – Germany
Tel (USA): 1-631-381-2994
Tel (Europe): 44-207-097-1828
Fax: 1-631-207-8356
Email: info@creative-biolabs.com

Copyright © Creative Biolabs Blog
Powered by WordPress , Designed and Developed by templatesnext